FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q45920933> ?p ?o ?g. }

• Q45920933 description "2015 nî lūn-bûn" @default.
• Q45920933 description "2015 թվականի նոյեմբերի 4-ին հրատարակված գիտական հոդված" @default.
• Q45920933 description "2015年の論文" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年学术文章" @default.
• Q45920933 description "2015年學術文章" @default.
• Q45920933 description "2015年學術文章" @default.
• Q45920933 description "2015年學術文章" @default.
• Q45920933 description "2015年學術文章" @default.
• Q45920933 description "2015年學術文章" @default.
• Q45920933 description "2015년 논문" @default.
• Q45920933 description "article científic" @default.
• Q45920933 description "article scientific" @default.
• Q45920933 description "article scientifique" @default.
• Q45920933 description "articol științific" @default.
• Q45920933 description "articolo scientifico" @default.
• Q45920933 description "artigo científico" @default.
• Q45920933 description "artigo científico" @default.
• Q45920933 description "artigo científico" @default.
• Q45920933 description "artikel ilmiah" @default.
• Q45920933 description "artikull shkencor" @default.
• Q45920933 description "artikulong pang-agham" @default.
• Q45920933 description "artykuł naukowy" @default.
• Q45920933 description "artículo científico publicado en 2015" @default.
• Q45920933 description "artículu científicu" @default.
• Q45920933 description "bilimsel makale" @default.
• Q45920933 description "bài báo khoa học" @default.
• Q45920933 description "naučni članak" @default.
• Q45920933 description "scienca artikolo" @default.
• Q45920933 description "scientific article published on 4 November 2015" @default.
• Q45920933 description "scientific article published on 4 November 2015" @default.
• Q45920933 description "scientific article published on 4 November 2015" @default.
• Q45920933 description "teaduslik artikkel" @default.
• Q45920933 description "tieteellinen artikkeli" @default.
• Q45920933 description "tudományos cikk" @default.
• Q45920933 description "vedecký článok" @default.
• Q45920933 description "vetenskaplig artikel" @default.
• Q45920933 description "videnskabelig artikel" @default.
• Q45920933 description "vitenskapelig artikkel" @default.
• Q45920933 description "vitskapeleg artikkel" @default.
• Q45920933 description "vědecký článek" @default.
• Q45920933 description "wetenschappelijk artikel" @default.
• Q45920933 description "wissenschaftlicher Artikel" @default.
• Q45920933 description "επιστημονικό άρθρο" @default.
• Q45920933 description "мақолаи илмӣ" @default.
• Q45920933 description "наукова стаття, опублікована в листопаді 2015" @default.
• Q45920933 description "научна статия" @default.
• Q45920933 description "научная статья" @default.
• Q45920933 description "научни чланак" @default.
• Q45920933 description "научни чланак" @default.
• Q45920933 description "מאמר מדעי" @default.
• Q45920933 description "مقالة علمية نشرت في 4 نوفمبر 2015" @default.
• Q45920933 description "৪ নভেম্বর ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q45920933 description "บทความทางวิทยาศาสตร์" @default.
• Q45920933 description "სამეცნიერო სტატია" @default.
• Q45920933 name "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial." @default.
• Q45920933 name "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer" @default.
• Q45920933 type Item @default.
• Q45920933 label "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial." @default.
• Q45920933 label "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer" @default.
• Q45920933 prefLabel "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial." @default.
• Q45920933 prefLabel "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer" @default.
• Q45920933 P1433 Q45920933-11B3F1C9-095E-4DA4-B394-F236FC2A5A54 @default.
• Q45920933 P1476 Q45920933-DFAEAB7B-7AEB-422B-B854-E7BC03195090 @default.
• Q45920933 P2093 Q45920933-191E38A9-C916-4A0C-950E-732849D78025 @default.
• Q45920933 P2093 Q45920933-48D7324C-4AC2-41B2-A9FE-5AEB4D2651C9 @default.
• Q45920933 P2093 Q45920933-55D31720-94DF-4CE3-B0C9-4185F42422AB @default.
• Q45920933 P2093 Q45920933-59DB478A-BCC0-45BE-9A7F-23977DFFBCA8 @default.
• Q45920933 P2093 Q45920933-62128865-1BE6-4362-A446-52C4F29566D0 @default.
• Q45920933 P2093 Q45920933-9086335B-AC20-4B0F-AE9A-558D9B838F14 @default.
• Q45920933 P2093 Q45920933-945F6AE0-E24A-43F8-98EF-C352196A2F58 @default.
• Q45920933 P2093 Q45920933-D82DF2DD-5344-4ED4-BE5F-FBE98098CD37 @default.
• Q45920933 P2093 Q45920933-DE2CA268-1CD1-469B-AEEC-4E84FB6C7B9B @default.
• Q45920933 P2093 Q45920933-DEAF0675-F0B1-4CB7-A73F-87509B9CF466 @default.
• Q45920933 P2093 Q45920933-E98406C7-26E9-4F40-B153-075B3A98EF4B @default.
• Q45920933 P2093 Q45920933-F8DA6C71-C09C-4C84-BAF5-0CF6BE8741BC @default.
• Q45920933 P2093 Q45920933-FD04AB46-2147-4E73-8300-FD27A18A9360 @default.
• Q45920933 P2888 Q45920933-AB72279A-D2D7-489D-A837-5651546AEC5F @default.
• Q45920933 P304 Q45920933-FEA94D32-40C8-4DCF-A57A-73244BCC95C9 @default.
• Q45920933 P31 Q45920933-4957AE3C-F4CA-4E91-80DE-041EDC0A7AA4 @default.
• Q45920933 P356 Q45920933-962A3194-DC3D-4865-8574-CBA41CC4C146 @default.
• Q45920933 P433 Q45920933-512DA81B-E04C-4B5F-9D1A-5D13E9579BB7 @default.
• Q45920933 P478 Q45920933-27B0E349-1B23-4CCB-A686-04DADD21ABA5 @default.
• Q45920933 P50 Q45920933-51861FDD-2501-4813-B35F-8476F3D2A915 @default.
• Q45920933 P50 Q45920933-6F5878F9-F857-46A9-A6D9-242B2F9E5FDC @default.
• Q45920933 P50 Q45920933-7457045A-73BA-4CDD-BFA1-5A0D1AC0521D @default.
• Q45920933 P50 Q45920933-EEED38EE-0646-46C5-85FE-A9193A669450 @default.
• Q45920933 P577 Q45920933-90F92C62-3C72-4210-A8B1-E22DB3E0ABFD @default.
• Q45920933 P6179 Q45920933-FA7EFBAB-35F7-4EA3-BD71-526EB8138CB8 @default.
• Q45920933 P8608 Q45920933-15FD1207-85D1-4E3F-851A-EE162C65BF11 @default.
• Q45920933 P921 Q45920933-A037192C-5642-47A5-9A4B-B63495F86FB3 @default.
• Q45920933 P932 Q45920933-815C4600-4485-482B-ACD1-42AFA9E2D12F @default.
• Q45920933 P356 2051-1426-3-S2-P441 @default.
• Q45920933 P1433 Q27725163 @default.
• Q45920933 P1476 "TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial." @default.
• Q45920933 P2093 "Alexandra Szczesna" @default.

• next